Episode

E21: NDRI: Bupropion (Wellbutrin)

Podcast
This Is Your Brain On Drugs Psychiatry Podcast
Published
Jan 7, 2025
Duration seconds
4382
Processing state
not_requested
Canonical source
https://feeds.podcastle.ai/12462768-a493-4842-b2d9-dd5c6fb97e68/21%20NDRI%20Bupropion.mp3
Audio
https://feeds.podcastle.ai/12462768-a493-4842-b2d9-dd5c6fb97e68/21%20NDRI%20Bupropion.mp3
JSON
/v1/public/podcasts/this-is-your-brain-on-drugs-psychiatry-podcast-7023342/episodes/e21-ndri-bupropion-wellbutrin
Markdown
/podcast/this-is-your-brain-on-drugs-psychiatry-podcast-7023342/e21-ndri-bupropion-wellbutrin.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/this-is-your-brain-on-drugs-psychiatry-podcast-7023342/episodes/e21-ndri-bupropion-wellbutrin/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/this-is-your-brain-on-drugs-psychiatry-podcast-7023342/e21-ndri-bupropion-wellbutrin.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

For today's antidepressant category of norepinephrine and dopamine reuptake inhibitor, we just have one medication, bupropion, but it is a very special antidepressant because its adverse effect profile is so much different than all of the other antidepressants we have talked about, and it is this adverse effect profile that makes bupropion often my first choice for patients not only for depression but also anxiety. Listen and find out why!